Lilly Edges Past Profit Targets
- Loading Comments...
Eli Lilly(LLY Quote) Tuesday delivered a penny per-share earnings beat for its fourth quarter, benefiting from the foreign exchange rate and sales growth in drugs like antidepressant Cymbalta and erectile-dysfunction drug Cialis. Those sales helped to offset a flat quarter for its leading earner, schizophrenia drug Zyprexa.
Shares rose $1.22, or 2.4%, to $52.59 Tuesday morning.
The company said Tuesday that net income came in at $854.4 million, or 78 cents a share, vs. $132 million and 12 cents a share in the year-ago quarter when Lilly recognized asset impairment, restructuring and Zyprexa product liability charges of 73 cents a share. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,388.90 | 1,105.98 | 2,194.35 | 34.83 |
Oil *
77.74
|
|
UP
22.75
|
UP
6.06
|
UP
21.21
|
UP
1.03
|
10 Yr
3.48%
SPDR Gold
113.75
|
|
+0.22%
|
+0.55%
|
+0.98%
|
+3.05%
|
Data delayed 20 minutes |


Connect with TheStreet